First Time Loading...

Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 4.19 EUR -0.95% Market Closed
Updated: Jun 1, 2024

Genoway SA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genoway SA
Operating Income Peer Comparison

Comparables:
VLA
NANO
IPH
G
GNFT
ABVX

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Genoway SA
PAR:ALGEN
Operating Income
€1.7m
CAGR 3-Years
N/A
CAGR 5-Years
14%
CAGR 10-Years
50%
Valneva SE
PAR:VLA
Operating Income
-€126.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanobiotix SA
PAR:NANO
Operating Income
-€26.8m
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
-13%
Innate Pharma SA
PAR:IPH
Operating Income
-€12.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-16%
G
Genfit SA
PAR:GNFT
Operating Income
-€26.7m
CAGR 3-Years
30%
CAGR 5-Years
17%
CAGR 10-Years
-10%
Abivax SA
PAR:ABVX
Operating Income
-€127.4m
CAGR 3-Years
-50%
CAGR 5-Years
-46%
CAGR 10-Years
N/A

See Also

What is Genoway SA's Operating Income?
Operating Income
1.7m EUR

Based on the financial report for Jun 30, 2023, Genoway SA's Operating Income amounts to 1.7m EUR.

What is Genoway SA's Operating Income growth rate?
Operating Income CAGR 10Y
50%

Over the last year, the Operating Income growth was 213%.